Literature DB >> 10711307

Avoiding adverse reactions. Effective lower-dose drug therapies for older patients.

J S Cohen1.   

Abstract

Adverse drug reactions (ADRs) are a leading cause of morbidity and mortality, with the highest incidence occurring in patients age 60 and older. Prescribing the lowest effective doses of medications to older patients can help avoid ADRs, minimize bothersome side effects, and increase rates of compliance. For many drugs, clinical experience and published studies demonstrate the effectiveness of doses substantially lower than those recommended in standard references. This article examines the problem of ADRs in older patients, discusses pharmacokinetic data regarding older versus younger adults, and provides effective lower doses for many common drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711307

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  9 in total

Review 1.  Combination therapy for osteoporosis: considerations and controversy.

Authors:  Neil Binkley; Diane Krueger
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

Review 2.  Combination therapy for osteoporosis: considerations and controversy.

Authors:  Neil Binkley; Diane Krueger
Journal:  Curr Osteoporos Rep       Date:  2005-12       Impact factor: 5.096

Review 3.  Medication errors: problems and recommendations from a consensus meeting.

Authors:  Abha Agrawal; Jeffrey K Aronson; Nicky Britten; Robin E Ferner; Peter A de Smet; Daniela Fialová; Richard J Fitzgerald; Robert Likić; Simon R Maxwell; Ronald H Meyboom; Pietro Minuz; Graziano Onder; Michael Schachter; Giampaolo Velo
Journal:  Br J Clin Pharmacol       Date:  2009-06       Impact factor: 4.335

Review 4.  A composite screening tool for medication reviews of outpatients: general issues with specific examples.

Authors:  Peter A G M De Smet; Wilma Denneboom; Cees Kramers; Richard Grol
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 5.  Repeat prescribing: scale, problems and quality management in ambulatory care patients.

Authors:  Peter A G M De Smet; Maaike Dautzenberg
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes.

Authors:  Beatrice A Golomb; Michael H Criqui; Halbert L White; Joel E Dimsdale
Journal:  Control Clin Trials       Date:  2004-04

7.  Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers.

Authors:  Corrado Blandizzi; Giuseppe Claudio Viscomi; Carmelo Scarpignato
Journal:  Drug Des Devel Ther       Date:  2014-12-16       Impact factor: 4.162

8.  Lower-dose prescriptions in the post-marketing situation and the influencing factors thereon.

Authors:  Akiko Ogata; Masayuki Kaneko; Mamoru Narukawa
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

9.  Association between physician specialty and risk of prescribing inappropriate pill splitting.

Authors:  Chia-Yu Chou; Chia-Chen Hsu; Shu-Chiung Chiang; Chin-Chin Ho; Chia-Lin Chou; Min-Shan Wu; Yuh-Lih Chang; Han-Yi Tsai; Tzeng-Ji Chen; Yueh-Ching Chou
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.